Pat Shafer
Company: FTI Consultant
Job title: Managing Director – Life Sciences Operations, Regulatory & Quality
Seminars:
Preparing for the Unknown – Mitigating Risk of Process Disruption as Your Therapy Evolves 9:20 am
As cell and gene therapies are scaling from early-stage clinical to late-stage clinical or commercial operations, the manufacturer will need to address different types of risks Identifying and realizing the existence of these risks should be accomplished through performing regular business risk reviews and assessments Being prepared to address the time-criticality of process-steps along the…Read more
day: Conference Day Two